Natrapharm
   Patriot Pharmaceutical Corp.   
Home | Contact Us | Sitemap    
Products
 
Natrapharm, Inc.
 
Patriot Pharmaceutical Corp.

Home » Products » Omacor
 

IMPORTANT:  THIS IS A PRESCRIPTION DRUG. 

Caution:  Foods, Drugs, Devices and Cosmetics Act prohibit dispensing without prescription.

The contents of this page are provided for information purposes only.  It should not be construed as a substitute for a professional medical advice.  Please consult your physician and other healthcare providers before taking any medicines found in this page.   

   


BASF AS

[Patriot]

Regulatory Class: Rx

C: EPA 460 mg, DHA 380 mg

I: Isolated or predominant endogenous hypertriglyceridemia in patient at risk of ischemic heart disease &/or pancreatitis. Supplement to diet when appropriate & assiduous dietary measures alone are insufficient to produce an adequate response. Secondary prevention after MI.

D: Post MI 1 cap daily. Hypertriglyceridemia Initially 2 cap daily may be increased to 4 cap daily.

A:  Take w/ food to avoid GI disturbances.

CI: Hypersensitivity to EPA or DHA, soya (soya milk, soya beans).

SP: Thromboxane A2 production may fall during treatment. Monitor patients receiving anticoagulant or other drugs affecting coagulation (eg, ASA, warfarin & coumarin). Routine monitoring of the entire lipid profile; LDL-C especially in patients w/ type IV & V dyslipidemia. Not recommended as monotherapy in type IIb dyslipidemia. Regular monitoring of hepatic function (especially ALT) in patients w/ hepatic impairment. Pregnancy & lactation. Not recommended in childn.

AR: Dyspepsia, nausea. Post MI: GI disturbances. Hypertriglyceridemia: Eructation taste perversion.

INT: Increased bleeding time w/ acetylsalicylic acid; warfarin & coumarin.

P/P: Softgel cap 28's.

Click here to view the full product information 




The Company

Corporate Services

Careers at Natrapharm
Home | The Company | Corporate Values | Corporate Services | Products | About the Philippines | Careers | Contact Us | Sitemap